Tarsus hosts investor webcast on TP-03 commercialization strategy; no new material financial data disclosed

Tarsus Pharmaceuticals, Inc.

Company hosted Virtual Investor Webcast on June 15, 2023, with corporate presentation on TP-03 for Demodex blepharitis.
Presentation posted to investor section of website; no specific financial results or guidance provided.
No material changes to business or financial condition disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.